Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 1,982.00
-16.00 (-0.80%)
At close: Oct 23, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 195.09 billion as of October 23, 2026. It is the 22,541st most valuable company in the world and the 830th biggest in South Korea. Its market cap has increased by 86.09% in one year.
Market Cap
195.09B
Enterprise Value
161.26B
Revenue
26.22B
Global Rank
Country Rank
#830 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 195.09B, an increase of 159.02%. That is a compound annual growth rate of 9.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 195.09B | 26.23% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 3billion | 168.02B |
| GC Medical Science | 97.05B |
| Inventera | 71.97B |
| Protia | 71.48B |
| HLB Panagene | 66.33B |
| GENINUS | 62.20B |
| Cytogen | 61.75B |
| Seoulin Bioscience | 34.86B |